KRAS mutated advanced solid tumors research hub

C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors

This study is for people with certain advanced cancers that have a specific genetic change called a 'KRAS mutation'. It's the first time a new medicine, PF-07985045, is being tested in humans to see if it's safe and how it works in the body.